New York Life Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1M | Buy |
205,857
+3,790
| +2% | +$407K | 0.21% | 94 |
|
|
2025
Q1 | $20.4M | Sell |
202,067
-1,227
| -0.6% | -$124K | 0.21% | 102 |
|
|
2024
Q4 | $18.2M | Buy |
203,294
+2,488
| +1% | +$222K | 0.18% | 108 |
|
|
2024
Q3 | $16.8M | Sell |
200,806
-6,082
| -3% | -$510K | 0.16% | 122 |
|
|
2024
Q2 | $15.9M | Buy |
206,888
+1,017
| +0.5% | +$78.3K | 0.16% | 128 |
|
|
2024
Q1 | $14.1M | Sell |
205,871
-7,232
| -3% | -$495K | 0.14% | 140 |
|
|
2023
Q4 | $12.3M | Sell |
213,103
-1,207
| -0.6% | -$69.8K | 0.13% | 150 |
|
|
2023
Q3 | $11.3M | Buy |
214,310
+6,039
| +3% | +$319K | 0.12% | 151 |
|
|
2023
Q2 | $11.3M | Buy |
208,271
+2,020
| +1% | +$109K | 0.12% | 157 |
|
|
2023
Q1 | $10.3M | Buy |
206,251
+872
| +0.4% | +$43.6K | 0.11% | 179 |
|
|
2022
Q4 | $9.5M | Sell |
205,379
-527
| -0.3% | -$24.4K | 0.11% | 199 |
|
|
2022
Q3 | $7.97M | Buy |
205,906
+1,414
| +0.7% | +$54.8K | 0.1% | 221 |
|
|
2022
Q2 | $7.62M | Buy |
+204,492
| New | +$7.62M | 0.09% | 238 |
|